PMC:7532482 / 5114-6133
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T38 | 662-670 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T39 | 864-872 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T40 | 935-943 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T39 | 24-25 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T40 | 139-145 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signal |
T41 | 256-265 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T42 | 351-357 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T43 | 413-418 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | genes |
T44 | 542-547 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | genes |
T45 | 949-955 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T46 | 976-981 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | genes |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T32 | 169-173 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T33 | 392-400 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
T34 | 602-605 | Chemical | denotes | TCM | http://purl.obolibrary.org/obo/CHEBI_145500 |
T35 | 609-612 | Chemical | denotes | TCM | http://purl.obolibrary.org/obo/CHEBI_145500 |
T36 | 696-704 | Chemical | denotes | solution | http://purl.obolibrary.org/obo/CHEBI_75958 |
T37 | 781-786 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
126 | 662-670 | Disease | denotes | COVID-19 | MESH:C000657245 |
127 | 825-843 | Disease | denotes | QingFei PaiDu Tang | MESH:C536897 |
128 | 864-872 | Disease | denotes | COVID-19 | MESH:C000657245 |
129 | 935-943 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 242-274 | http://purl.obolibrary.org/obo/GO_0009966 | denotes | regulation of signaling pathways |
T2 | 242-265 | http://purl.obolibrary.org/obo/GO_0023051 | denotes | regulation of signaling |
T3 | 242-252 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulation |
T4 | 256-265 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T5 | 283-293 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T35 | 0-191 | Sentence | denotes | Network pharmacology is a new discipline based on the theory of system biology, which analyzes the biological systems and selects specific signal nodes for multi-target drug molecular design. |
T36 | 192-460 | Sentence | denotes | Network pharmacology emphasizes the multi-pathway regulation of signaling pathways and the regulation of multi-component, multi-target, multi-pathway, linking active components in traditional chinese medicine with target genes from molecular and biological aspects 23. |
T37 | 461-623 | Sentence | denotes | Network pharmacology will help to understand the relationship among ingredients, genes and diseases and is suitable for the study of complex TCM or TCM compounds. |
T38 | 624-767 | Sentence | denotes | The potential mechanism of preventing COVID-19 by HuoXiang ZhengQi oral solution was realized by network pharmacology and molecular docking 24. |
T39 | 768-903 | Sentence | denotes | The research group Jing Zhao elucidated the mechanism of QingFei PaiDu Tang in the treatment of COVID-19 using network pharmacology 25. |
T40 | 904-1019 | Sentence | denotes | SFJDC could be efficacious for COVID-19, but active incredients, target genes and putative mechanism are not known. |